GRP
AMLX icon

Global Retirement Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History

Global Retirement Partners’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251 Buy
+14
New +$217 ﹤0.01% 4363
2025
Q4 		– Sell
-1,000
Closed -$13.6K – 4237
2025
Q3 		$13.6K Sell
1,000
-1,500
-60% -$14.1K ﹤0.01% 2565
2025
Q2 		$16K Buy
+2,500
New +$12.2K ﹤0.01% 2392
2024
Q4 		$1.51K Buy
+400
New +$1.88K ﹤0.01% 3171
2024
Q1 		– Sell
-200
Closed -$3.1K – 3388
2023
Q4 		$3.1K Buy
+200
New +$3.06K ﹤0.01% 2509

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Global Retirement Partners's AMLX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Amylyx Pharmaceuticals (AMLX) in Q2 2026: 14 shares worth $251. The stake represents ﹤0.01% of the portfolio and ranks #4363 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in AMLX as recently as Q3 2025.

Global Retirement Partners first reported a position in AMLX in Q4 2023 and has held it in 5 quarters since. The position peaked at $16K in Q2 2025. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Global Retirement Partners held 14 shares of Amylyx Pharmaceuticals worth $251 as of Q2 2026.
  • Amylyx Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4363 holding.
  • Global Retirement Partners first reported a position in Amylyx Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Global Retirement Partners's Amylyx Pharmaceuticals position peaked at $16K in Q2 2025.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.